This is a stem cell company, but so what? It still has to overcome the same hurdles as any other organisation developing therapeutics. And in direct response to your point: the world is awash with drugs that successfully got through Phase 3, whereas it is NOT awash with stem cell therapeutics. On the contrary, there have been multiple failures.
As we've discussed and (gasp!) agreed previously, stem cells are unquestioningly safe to administer. The question as to whether they are efficacious will remain moot until such time as they have successfully negotiated a Phase 3 programme. You seem to think that this is a slam dunk, presumably based upon the post-hoc analysis of the Phase 2 data, but then you think that the stem cell DNA interreacts with biologicalisation high up the pharmaceuticaloid chainosomes. Or something. I confess, I'm a little hazy on the precise details of your scientific rationale.
And now, I can't be bothered with you again any more.
This is a stem cell company, but so what? It still has to...
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |